Previous close | 12.95 |
Open | 12.97 |
Bid | 12.52 x 300 |
Ask | 12.57 x 400 |
Day's range | 12.40 - 13.07 |
52-week range | 5.71 - 16.99 |
Volume | |
Avg. volume | 840,275 |
Market cap | 954.149M |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.21 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 23.86 |
With the business potentially at an important milestone, we thought we'd take a closer look at Liquidia Corporation's...
Key Insights Given the large stake in the stock by institutions, Liquidia's stock price might be vulnerable to their...
MORRISVILLE, N.C., April 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that Dr. Roger Jeffs, Chief Executive Officer, and Micheal Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an overview and update on the company's business during a fireside chat session at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, beginning at 1:30 p.m. Eastern Time. Access to a webcast will be availa